NAC: the supplement sold as a mental balm that only holds up in one disorder

NAC: plenty of mental buzz, little solid evidence

Can a pharmacy antioxidant replace a psychiatrist? N-acetylcysteine (NAC) has slipped into the mental health conversation as an almost miraculous supplement: it is credited with improvements in bipolar disorder, schizophrenia, obsessive-compulsive disorder, addictions and trichotillomania. The supposed mechanism is specific: it provides cysteine, the limiting ingredient for producing glutathione, and modulates glutamate through the cystine-glutamate antiporter. From there to a cure is a long stretch.

The most striking figure comes from a randomized, placebo-controlled trial in 50 adults with trichotillomania: roughly 56% of those who took NAC experienced a substantial clinical improvement versus 16% in the placebo group after 12 weeks. It is the result that underpins much of the enthusiasm. The fine print: it was a small study, in adults, and a later trial in children and adolescents found no difference from placebo.

Schizophrenia and bipolar: results that fail to replicate

In schizophrenia, some randomized controlled trials reported improvements in negative symptoms —lack of motivation, social withdrawal, reduced emotional expression— when NAC was added to standard antipsychotic treatment. In bipolar disorder, early clinical studies suggested improvements in depressive symptoms and functional outcomes. The larger trials that came later did not replicate those results with the same force.

The practical consensus that emerges is modest: NAC may have potential as an add-on treatment, never as a substitute for established psychiatric medication. Most psychiatric studies have tested it over periods of 8 to 24 weeks, and the most commonly reported adverse effect is gastrointestinal discomfort.

Glutathione and paracetamol: where NAC truly is beyond dispute

NAC does not enter the Krebs cycle or directly boost ATP, however widely that version circulates. What it does is supply the limiting amino acid for producing glutathione, the cell's main antioxidant. That is why it is used in hospitals for paracetamol overdose, and why liver and respiratory effects are also attributed to it. There the evidence is solid; in psychiatry, things get murkier.

Some take the thesis further and argue that psychiatric disorders are actually metabolic problems that manifest in the cells of the nervous system. That mitochondrial and inflammatory alterations exist in some patients is well studied. Turning it into a universal explanation is another matter: genetics, neurodevelopment, stress and environment also come into play.

Dementia, sun and vitamin D: the rest of the cocktail

The hardest case to attribute is dementia. There are no solid trials showing improvement with NAC alone, and the disease fluctuates enough that a perceived improvement proves nothing. At the opposite end of the counter, the most repeated prescription costs nothing: sunlight, exercise, real food and sleeping in line with the natural cycle. Vitamin D appears as a low-cost antidepressant, with the caveat that megadoses carry a risk of hypercalcemia and require medical supervision.

The supplement is sold online, is scarce in pharmacies and has become a cult object for longevity biohacking. The question is not whether glutathione is good. It is how much of that promise survives comparison with a large trial.